Literature DB >> 19054640

Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization.

Davide Ippolito1, Sandro Sironi, Massimo Pozzi, Laura Antolini, Francesca Invernizzi, Laura Ratti, Eugenio Biagio Leone, Ferruccio Fazio.   

Abstract

PURPOSE: To assess the value of CT-perfusion in determining the quantitative vascularization features of early hepatocellular carcinoma (HCC) in cirrhotic patients.
MATERIALS AND METHODS: A total of 35 cirrhotic patients with single histologically proven HCC not exceeding 3cm in diameter underwent conventional triple-phase multidetector computed tomography (MDCT) examination. All patients were also examined with CT-perfusion (CTp) technique after i.v. injection of 50mL of iodinated contrast. Data were analyzed using a dedicated software which generated a quantitative map of liver parenchyma perfusion. The following parameters were assessed: hepatic perfusion (HP); blood volume (BV); arterial perfusion (AP); time to peak (TTP) and hepatic perfusion index (HPI). Univariate Wilcoxon signed rank test was used for statistical analysis.
RESULTS: In the 35 HCCs evaluated, the following quantitative data were obtained: HP (mL/s/100g): median=47.0 (1(st)qt=35.5; 3(st)qt=61.2); BV (mL/100mg): median=22.5 (1(st)qt=18.4; 3(st)qt=27.7); AP (mL/min): median=42.9 (1(st)qt=35.8; 3(st)qt=55.6); HPI(%): median=75.3 (1(st)qt=63.1; 3(st)qt=100); TTP(s): median=18.7 (1(st)qt=16.8; 3(st)qt=24.5). Perfusion values calculated in cirrhotic liver parenchyma were HP: median=10.3 (1(st)qt=9.1; 3(st)qt=13.2); BV: median=11.7 (1(st)qt=9.6; 3(st)qt=15.5); AP: median=10.4 (1(st)qt=8.6; 3(st)qt=11.3); HPI: median=17.5 (1(st)qt=14.3; 3(st)qt=19.7); TTP: median=44.6 (1(st)qt=40.3; 3(st)qt=50.1). HP, BV, HPI and AP were found to be significantly higher in HCC lesion than in liver parenchyma (p<0.001), while TTP was significantly lower (p<0.001).
CONCLUSION: CT-perfusion technique allows obtaining quantitative information about tumor-related vascularization of early HCC, in patients with liver cirrhosis. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2008        PMID: 19054640     DOI: 10.1016/j.ejrad.2008.10.014

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  20 in total

1.  Hepatic computed tomography perfusion: comparison of maximum slope and dual-input single-compartment methods.

Authors:  Tomonori Kanda; Takeshi Yoshikawa; Yoshiharu Ohno; Naoki Kanata; Hisanobu Koyama; Munenobu Nogami; Daisuke Takenaka; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2010-12-30       Impact factor: 2.374

2.  Novel imaging biomarkers of response to transcatheter arterial chemoembolization in hepatocellular carcinoma patients.

Authors:  Sylvain Favelier; Louis Estivalet; Pierre Pottecher; Romaric Loffroy
Journal:  Chin J Cancer Res       Date:  2015-12       Impact factor: 5.087

Review 3.  Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome.

Authors:  Adam S Bodzin; Ronald W Busuttil
Journal:  World J Hepatol       Date:  2015-05-28

Review 4.  Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma.

Authors:  Tiffany Hennedige; Sudhakar K Venkatesh
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

5.  Hepatocellular carcinoma: perfusion quantification with dynamic contrast-enhanced MRI.

Authors:  Bachir Taouli; R Scott Johnson; Cristina H Hajdu; Marcel T H Oei; Miriam Merad; Herman Yee; Henry Rusinek
Journal:  AJR Am J Roentgenol       Date:  2013-10       Impact factor: 3.959

Review 6.  Recent Advances in CT and MR Imaging for Evaluation of Hepatocellular Carcinoma.

Authors:  Jeong Min Lee; Jeong-Hee Yoon; Ijin Joo; Hyun Sik Woo
Journal:  Liver Cancer       Date:  2012-06       Impact factor: 11.740

7.  [Perfusion computed tomography for diffuse liver diseases].

Authors:  S A Schmidt; M S Juchems
Journal:  Radiologe       Date:  2012-08       Impact factor: 0.635

8.  Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma.

Authors:  Michael A Fischer; Herman P Marquez; Sonja Gordic; Bertil Leidner; Ernst Klotz; Peter Aspelin; Hatem Alkadhi; Torkel B Brismar
Journal:  Eur Radiol       Date:  2016-07-01       Impact factor: 5.315

Review 9.  CT perfusion of the liver: principles and applications in oncology.

Authors:  Se Hyung Kim; Aya Kamaya; Jürgen K Willmann
Journal:  Radiology       Date:  2014-08       Impact factor: 11.105

10.  Iodine concentration as a perfusion surrogate marker in oncology: Further elucidation of the underlying mechanisms using Volume Perfusion CT with 80 kVp.

Authors:  Wolfgang M Thaiss; Ulrike Haberland; Sascha Kaufmann; Daniel Spira; Christoph Thomas; Konstantin Nikolaou; Marius Horger; Alexander W Sauter
Journal:  Eur Radiol       Date:  2015-12-17       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.